Read-To The Moon - Tiger Brokers Online Investing Community

Like
Comment
Favorite

Jo9987
2021-08-26

Read

ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?

In recent days,meme stockshave turned green in a big way. Shares of GameStop(NYSE:GME) and AMC Enter

ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":810164761,"tweetId":"810164761","gmtCreate":1629953478653,"gmtModify":1676530183042,"author":{"id":3577201937137929,"authorId":3577201937137929,"authorIdStr":"3577201937137929","name":"Jo9987","avatar":"https://static.tigerbbs.com/773111900bb81d2470405d05d66517e8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Read&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Read&nbsp;</p></body></html>","text":"Read","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/810164761","repostId":1158694629,"repostType":4,"repost":{"id":"1158694629","pubTimestamp":1629947228,"share":"https://www.laohu8.com/m/news/1158694629?lang=&edition=full","pubTime":"2021-08-26 11:07","market":"us","language":"en","title":"ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?","url":"https://stock-news.laohu8.com/highlight/detail?id=1158694629","media":"investorplace","summary":"In recent days,meme stockshave turned green in a big way. Shares of GameStop(NYSE:GME) and AMC Enter","content":"<p>In recent days,meme stockshave turned green in a big way. Shares of&nbsp;<b>GameStop</b>(NYSE:<b><u>GME</u></b>) and&nbsp;<b>AMC Entertainment</b>(NYSE:<b><u>AMC</u></b>) are both up big over the past week. Investors in&nbsp;<b>Zomedica</b>(NYSE:<b><u>ZOM</u></b>) and&nbsp;ZOM stock appear to be riding these coattails.</p>\n<p>Indeed, ZOM stock has surged from under 50 cents per share this time last week to as high as 67 cents today. This move has been driven, at least in part, by surging retail investor interest.</p>\n<p>Today, social media is exploding with interest in ZOM stock as it shoots 20% higher. Some retail traders think Zomedica isheaded for the $1 levelin short order. As a highly shorted stock, Zomedica is a company that is in the crosshairs of short-squeeze speculators. The company’s recent rallies provide credence to this thesis and allow investors’&nbsp;imaginations&nbsp;to run wild.</p>\n<p>However, some retail traders may be cautious with Zomedica. After all, this is a company that has seen an absolutely massive 52-week range of 6 cents to $2.91. Volatility is the name of the game with these meme-stock plays, making this stock well-suited for those with a penchant for high-risk, high-reward plays.</p>\n<p>Let’s take a look at some of the catalysts Zomedica bulls are pointing to as reasons to buy into this risk-reward today.</p>\n<p>ZOM Stock Surging on Retail Investor Interest</p>\n<p>One of the key catalysts fellow&nbsp;<i>InvestorPlace</i>contributor David Moadel pointed out in arecent pieceis the commercialization timeline of Zomedica’s proprietary TRUFORMA platform. This veterinary diagnostics tool has seen limited adoption thus far. The company notes this in its recent earnings releases. However, the company expects the fourth quarter to bring higher sales. This is a result of a fT4 assay which will be available for commercial sale later this year.</p>\n<p>“We expect that the fT4 assay will be available for commercial sale in the fall of 2021 and that the ACTH assay will be available for commercial sale by the end of 2021,” Zomedica assured.</p>\n<p>It appears investors are demanding immediate results for Zomedica. For investors who believe in this company’s product pipeline and sales funnel, there’s little to worry about. However, as with other execution-based bets, there is some level of risk. Today, investors appear to be taking a risk-on approach to such stocks.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 11:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/08/zom-stock-can-the-latest-meme-stocks-surge-take-zomedica-to-1/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In recent days,meme stockshave turned green in a big way. Shares of GameStop(NYSE:GME) and AMC Entertainment(NYSE:AMC) are both up big over the past week. Investors in Zomedica(NYSE:ZOM) and ZOM stock...</p>\n\n<a href=\"https://investorplace.com/2021/08/zom-stock-can-the-latest-meme-stocks-surge-take-zomedica-to-1/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://investorplace.com/2021/08/zom-stock-can-the-latest-meme-stocks-surge-take-zomedica-to-1/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158694629","content_text":"In recent days,meme stockshave turned green in a big way. Shares of GameStop(NYSE:GME) and AMC Entertainment(NYSE:AMC) are both up big over the past week. Investors in Zomedica(NYSE:ZOM) and ZOM stock appear to be riding these coattails.\nIndeed, ZOM stock has surged from under 50 cents per share this time last week to as high as 67 cents today. This move has been driven, at least in part, by surging retail investor interest.\nToday, social media is exploding with interest in ZOM stock as it shoots 20% higher. Some retail traders think Zomedica isheaded for the $1 levelin short order. As a highly shorted stock, Zomedica is a company that is in the crosshairs of short-squeeze speculators. The company’s recent rallies provide credence to this thesis and allow investors’ imaginations to run wild.\nHowever, some retail traders may be cautious with Zomedica. After all, this is a company that has seen an absolutely massive 52-week range of 6 cents to $2.91. Volatility is the name of the game with these meme-stock plays, making this stock well-suited for those with a penchant for high-risk, high-reward plays.\nLet’s take a look at some of the catalysts Zomedica bulls are pointing to as reasons to buy into this risk-reward today.\nZOM Stock Surging on Retail Investor Interest\nOne of the key catalysts fellow InvestorPlacecontributor David Moadel pointed out in arecent pieceis the commercialization timeline of Zomedica’s proprietary TRUFORMA platform. This veterinary diagnostics tool has seen limited adoption thus far. The company notes this in its recent earnings releases. However, the company expects the fourth quarter to bring higher sales. This is a result of a fT4 assay which will be available for commercial sale later this year.\n“We expect that the fT4 assay will be available for commercial sale in the fall of 2021 and that the ACTH assay will be available for commercial sale by the end of 2021,” Zomedica assured.\nIt appears investors are demanding immediate results for Zomedica. For investors who believe in this company’s product pipeline and sales funnel, there’s little to worry about. However, as with other execution-based bets, there is some level of risk. Today, investors appear to be taking a risk-on approach to such stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}